IDEXX Laboratories
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
50.8744.4838.6033.53
Price/Sales ratio
12.4411.3010.269.31
Earnings per Share (EPS)
$12.51$14.31$16.49$18.99

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
40.7935.1547.3952.1542.8552.5773.3275.3150.2354.5658.8742.85
Price/Sales ratio
4.994.215.926.977.309.3415.7617.4410.1312.5911.877.30
Price/Book Value ratio
63.14-80.26-97.11-253.67-1.69K126.7067.4981.3056.0431.0565.68-1.69K
Price/Cash Flow ratio
31.4631.2031.4536.7640.3848.9765.8274.2562.8250.8673.6340.38
Price/Free Cash Flow ratio
42.3650.6039.0046.2758.3073.9878.9388.2086.5559.65101.4458.30
Price/Earnings Growth ratio
14.442.552.452.430.953.621.962.67-7.082.16-8.483.62
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
54.92%55.57%54.94%55.73%56.09%56.73%58.04%58.76%59.52%59.81%59.52%56.09%
Operating Profit Margin
17.51%18.72%19.72%20.97%22.19%22.96%25.65%28.98%26.69%29.96%26.69%22.19%
Pretax Profit Margin
16.59%17.05%18.12%19.35%20.68%21.69%24.45%28.07%25.53%28.98%25.53%20.68%
Net Profit Margin
12.24%11.99%12.50%13.36%17.03%17.77%21.49%23.16%20.16%23.08%20.16%17.03%
Effective Tax Rate
26.20%29.65%31.00%30.91%17.62%18.08%12.06%17.48%21.03%20.36%21.03%17.62%
Return on Assets
13.14%13.02%14.50%15.35%24.52%23.34%25.35%30.56%24.72%25.92%41.27%24.52%
Return On Equity
154.79%-228.32%-204.92%-486.34%-3963.32%241.00%92.04%107.94%111.55%56.92%124.51%-3963.32%
Return on Capital Employed
46.20%48.51%58.75%58.26%64.06%49.93%40.57%55.68%59.48%47.52%219.48%64.06%
Liquidity Ratios
Current Ratio
0.920.950.900.960.840.931.82N/AN/AN/A0.890.84
Quick Ratio
0.720.730.730.800.620.661.460.890.591.170.410.66
Cash ratio
0.390.150.160.180.160.120.650.180.090.470.090.12
Days of Sales Outstanding
37.4342.9042.0443.4842.6346.6250.5348.3153.2152.7943.4242.63
Days of Inventory outstanding
87.3996.8572.1068.8065.0968.3567.4574.0598.5094.3698.5065.09
Operating Cycle
124.82139.76114.14112.29107.73114.98117.99122.36151.71147.15109.20107.73
Days of Payables Outstanding
24.3827.0027.4028.0426.1125.2923.9631.9729.5127.4529.5126.11
Cash Conversion Cycle
100.43112.7686.7484.2581.6189.6894.0290.39122.19119.7038.1989.68
Debt Ratios
Debt Ratio
0.640.790.780.730.650.530.390.370.490.291.290.65
Debt Equity Ratio
7.65-13.90-11.11-23.30-105.145.561.431.332.210.633.51-105.14
Long-term Debt to Capitalization
0.741.161.221.091.010.790.570.520.530.290.560.79
Total Debt to Capitalization
0.881.071.091.041.000.840.580.570.680.380.580.84
Interest Coverage Ratio
16.8610.5310.9211.0914.1417.8020.96N/AN/AN/A22.5414.14
Cash Flow to Debt Ratio
0.260.180.270.290.390.460.710.810.400.950.620.39
Company Equity Multiplier
11.77-17.53-14.12-31.66-161.6010.323.633.534.512.192.70-161.60
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.150.130.180.180.180.190.230.230.160.240.160.19
Free Cash Flow / Operating Cash Flow Ratio
0.740.610.800.790.690.660.830.840.720.850.720.69
Cash Flow Coverage Ratio
0.260.180.270.290.390.460.710.810.400.950.620.39
Short Term Coverage Ratio
0.420.370.540.561.001.5912.965.080.832.787.241.00
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A